Recent Research Analysts’ Ratings Updates for Ingevity (NGVT)

Share on StockTwits

A number of research firms have changed their ratings and price targets for Ingevity (NYSE: NGVT):

  • 10/19/2019 – Ingevity was upgraded by analysts at ValuEngine from a “sell” rating to a “hold” rating.
  • 10/15/2019 – Ingevity is now covered by analysts at Wells Fargo & Co. They set an “outperform” rating and a $100.00 price target on the stock.
  • 10/11/2019 – Ingevity was downgraded by analysts at ValuEngine from a “hold” rating to a “sell” rating.
  • 10/2/2019 – Ingevity was upgraded by analysts at ValuEngine from a “sell” rating to a “hold” rating.
  • 9/27/2019 – Ingevity had its price target lowered by analysts at BMO Capital Markets from $131.00 to $127.00. They now have an “outperform” rating on the stock.
  • 9/25/2019 – Ingevity had its price target lowered by analysts at Stifel Nicolaus from $109.00 to $99.00. They now have a “hold” rating on the stock.
  • 9/5/2019 – Ingevity was upgraded by analysts at Loop Capital from a “hold” rating to a “buy” rating.

NGVT stock opened at $84.61 on Wednesday. The company has a market capitalization of $3.56 billion, a P/E ratio of 20.49, a PEG ratio of 1.75 and a beta of 2.10. The company has a 50-day simple moving average of $84.00 and a 200 day simple moving average of $93.17. Ingevity Corp has a fifty-two week low of $72.59 and a fifty-two week high of $120.41. The company has a quick ratio of 1.25, a current ratio of 2.28 and a debt-to-equity ratio of 3.51.

Ingevity (NYSE:NGVT) last posted its quarterly earnings data on Wednesday, July 24th. The company reported $1.36 earnings per share for the quarter, topping the consensus estimate of $1.35 by $0.01. Ingevity had a net margin of 14.03% and a return on equity of 54.67%. The business had revenue of $352.80 million during the quarter, compared to the consensus estimate of $362.06 million. During the same quarter in the prior year, the company posted $1.12 earnings per share. The company’s quarterly revenue was up 14.3% compared to the same quarter last year. Equities analysts anticipate that Ingevity Corp will post 4.87 EPS for the current year.

A number of hedge funds and other institutional investors have recently modified their holdings of NGVT. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. boosted its position in Ingevity by 33.9% during the second quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 3,190 shares of the company’s stock worth $335,000 after purchasing an additional 808 shares during the period. Copper Rock Capital Partners LLC boosted its holdings in Ingevity by 29.9% in the second quarter. Copper Rock Capital Partners LLC now owns 298,968 shares of the company’s stock valued at $31,442,000 after acquiring an additional 68,896 shares during the last quarter. Braun Stacey Associates Inc. boosted its holdings in Ingevity by 10.4% in the second quarter. Braun Stacey Associates Inc. now owns 149,482 shares of the company’s stock valued at $15,721,000 after acquiring an additional 14,085 shares during the last quarter. RE Advisers Corp boosted its holdings in Ingevity by 24.1% in the second quarter. RE Advisers Corp now owns 49,654 shares of the company’s stock valued at $5,222,000 after acquiring an additional 9,654 shares during the last quarter. Finally, Moody Aldrich Partners LLC boosted its holdings in Ingevity by 58.2% in the second quarter. Moody Aldrich Partners LLC now owns 51,407 shares of the company’s stock valued at $5,406,000 after acquiring an additional 18,904 shares during the last quarter. 91.52% of the stock is owned by institutional investors.

Ingevity Corporation manufactures and sells specialty chemicals and carbon materials in the United States and internationally. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products primarily for use in gasoline vapor emission control systems in cars, trucks, motorcycles, and boats.

Read More: Why do companies engage in swaps?

Receive News & Ratings for Ingevity Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity Corp and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Pacific Biosciences of California  Expected to Announce Quarterly Sales of $25.47 Million
Pacific Biosciences of California Expected to Announce Quarterly Sales of $25.47 Million
IMAC Holdings Inc  Given $7.00 Average Target Price by Brokerages
IMAC Holdings Inc Given $7.00 Average Target Price by Brokerages
Zacks: Analysts Anticipate Spirit AeroSystems Holdings, Inc.  to Announce $1.67 Earnings Per Share
Zacks: Analysts Anticipate Spirit AeroSystems Holdings, Inc. to Announce $1.67 Earnings Per Share
Chemed Co.  Sees Large Increase in Short Interest
Chemed Co. Sees Large Increase in Short Interest
Inseego Corp  Sees Significant Growth in Short Interest
Inseego Corp Sees Significant Growth in Short Interest
3M Co  Short Interest Update
3M Co Short Interest Update


© 2006-2019 Ticker Report